Annual General Meeting - 26 November 2024

Dear Shareholder

 

 

On behalf of the Board of Cambium Bio Limited, I am pleased to invite you to the Annual General Meeting of Cambium Bio Limited.  This meeting will be held in person at the offices of the Company located at 16 Goodhope St Paddington NSW 2021 on Tuesday 26th November 2024 at 11:00am (Sydney time).

 

The Company’s General Meeting will be held in person.

 

A copy of the Notice of Meeting was released to the ASX today, to view and download a copy of the Notice of Meeting please visit the link above.

 

The items of business to be conducted at the 2024 Annual General Meeting are set out in the Notice of Meeting as the following Resolutions:

 

Resolution 1:  Adoption of the Remuneration Report

Resolution 2:  Re-election of a Director, Dr. Yu-Hung Sebastian Tseng

Resolution 3:  Re-election of a Director, Terence A Walts

Resolution 4:  Re-election of a Director, Dr. Edmund K Waller

Resolution 5:  Re-election of a Director, ChiTai Chang

            Resolution 6:  Approval of additional placement capacity under Listing Rule 7.1A

            Resolution 7:  Approval to issue up to AUD$5,000,000 worth of Shares

 

 The Notice of Meeting contains explanatory information regarding all items of business.

 

The Board recommends that shareholders vote in favour of all items of business.

 

Should any shareholder have any queries regarding their shareholding, or in respect of the Company’s GM, please contact Cambium Bio’s share registry, Link Market Services by phoning 1300 554 474 (within Australia) or +61 1300 554 474 (for shareholders located overseas).

 

You can also update your communication preferences to ensure you receive all future communication from the Company electronically, by updating your details online via https://investorcentre.linkgroup.com.

 

The Board of Cambium Bio looks forward to welcoming you to the Company’s General Meeting.

 

Yours faithfully

 

Barry Sechos

Chairman

Dear Shareholder,

On behalf of the Board of Cambium Bio Limited, I am pleased to invite you to the General Meeting of Cambium Bio Limited. This meeting will be held in person at the offices of the Company located at 16 Goodhope St Paddington NSW 2021 on Tuesday 25th June 2024 commencing at 1:00pm (Sydney time).

The Company’s General Meeting will be held in person.

A copy of the Notice of Meeting was released to the ASX today, to view and download a copy of the Notice of Meeting please visit the link above.

The items of business to be conducted at the 2024 General Meeting are set out in the Notice of Meeting as the following Resolutions: 

Resolution 1: Ratification of the issue of Shares - Tranche 1 Placement under Listing Rule 7.1 

Resolution 2: Ratification of issue of Shares - Tranche 1 Placement under Listing Rule 7.1A 

Resolution 3: Approval to issue Shares – Tranche 2 Placement to Sebastian Tseng and ZYBT 

Resolution 4: Approval to issue Shares – Tranche 2 Placement to Other Investors under Listing Rule 7.1 

Resolution 5: Share Consolidation. 


The Notice of Meeting contains explanatory information regarding all items of business. 


The Board recommends that shareholders vote in favour of all items of business. 


Should any shareholder have any queries regarding their shareholding, or in respect of the Company’s GM, please contact Cambium Bio’s share registry, Link Market Services by phoning 1300 554 474 (within Australia) or +61 1300 554 474 (for shareholders located overseas). 


You can also update your communication preferences to ensure you receive all future communication from the Company electronically, by updating your details online via https://investorcentre.linkgroup.com.

The Board of Cambium Bio looks forward to welcoming you to the Company’s General Meeting. 


Yours faithfully 



Barry Sechos 

Chairman 

Dear Shareholder,

On behalf of the Board of Cambium Bio Limited, I am pleased to invite you to the General Meeting of Cambium Bio Limited. This meeting will be held in person at the offices of the Company located at 16 Goodhope St Paddington NSW 2021 on Tuesday 25th June 2024 commencing at 1:00pm (Sydney time).

The Company’s General Meeting will be held in person.

A copy of the Notice of Meeting was released to the ASX today, to view and download a copy of the Notice of Meeting please visit the link above.

The items of business to be conducted at the 2024 General Meeting are set out in the Notice of Meeting as the following Resolutions: 

Resolution 1: Ratification of the issue of Shares - Tranche 1 Placement under Listing Rule 7.1 
Resolution 2: Ratification of issue of Shares - Tranche 1 Placement under Listing Rule 7.1A 
Resolution 3: Approval to issue Shares – Tranche 2 Placement to Sebastian Tseng and ZYBT 
Resolution 4: Approval to issue Shares – Tranche 2 Placement to Other Investors under Listing Rule 7.1 
Resolution 5: Share Consolidation. 

The Notice of Meeting contains explanatory information regarding all items of business. 

The Board recommends that shareholders vote in favour of all items of business. 

Should any shareholder have any queries regarding their shareholding, or in respect of the Company’s GM, please contact Cambium Bio’s share registry, Link Market Services by phoning 1300 554 474 (within Australia) or +61 1300 554 474 (for shareholders located overseas). 

You can also update your communication preferences to ensure you receive all future communication from the Company electronically, by updating your details online via https://investorcentre.linkgroup.com.

The Board of Cambium Bio looks forward to welcoming you to the Company’s General Meeting. 

Yours faithfully 


Barry Sechos 
Chairman